보고서 요약(국문)

시장 개요
전 세계 신장 기능 검사 시장은 2022년 9억 달러 규모에 도달했으며, 2030년까지 14억 달러 규모로 성장할 것으로 예상됩니다. 이 시장은 2023년부터 2030년까지 연평균 6.3%의 성장률을 보일 것으로 전망됩니다.
신장 기능 검사는 신장 기능 장애를 진단하고 의사가 적절한 약물을 처방하는 데 도움을 줍니다. 희석 검사, 청소율 검사 등 다양한 유형의 신장 기능 검사가 있습니다. 신장 기능 검사를 통해 체액 과다로 인한 배뇨 곤란, 손발 부종, 얼굴 부종과 같은 신장 질환을 진단할 수 있습니다.
시장 성장을 견인하는 요인으로는 FDA 승인 및 주요 업체들의 신장 기능 검사 신제품 출시 등이 있습니다. 예를 들어, 스마트폰 카메라를 의료기기에 통합하는 데 있어 세계적인 선두 기업인 Healthy.io는 2022년 7월 12일, Minuteful Kidney 검사가 미국 식품의약국(FDA)으로부터 가정용 510(k) 승인을 받았다고 발표했습니다.
시장 동향
신장 질환 유병률 증가가 신장 기능 검사 시장 성장을 견인할 전망
전 세계적으로 만성 신장 질환의 발병률과 유병률이 증가하는 추세는 전 세계 신장 기능 검사 시장 성장을 이끄는 주요 요인입니다. 예를 들어, 미국 국립당뇨병소화기신장질환연구소(NIDDK)의 2021년 자료에 따르면, 미국 성인 7명 중 1명 이상, 약 3,700만 명이 만성 신장 질환(CKD)을 앓고 있습니다.
당뇨병이나 고혈압이 있는 미국인의 경우 CKD 발병 위험이 더욱 높습니다. 당뇨병 환자의 약 3분의 1, 고혈압 환자의 약 5분의 1이 신장 질환을 앓고 있습니다.

또한, 미국 질병통제예방센터(CDC)의 2021년 미국 만성신장질환(CKD) 보고서에 따르면, CKD는 남성(12%)보다 여성(14%)에서 약간 더 흔하며, 비히스패닉계 흑인 성인(16%)이 비히스패닉계 백인 성인(13%)이나 비히스패닉계 아시아인(13%)보다 더 흔합니다. 따라서 CKD의 발생률 증가는 시장 성장을 촉진할 것입니다.
높은 진단 비용이 시장 성장을 저해할 것으로 예상됨
신장 기능 검사의 높은 비용과 신흥 및 개발도상국에서의 낮은 수용률은 시장 성장을 저해할 것입니다. 수정된 공식으로 인해 임상적으로 신장 질환 진단을 받는 사람이 증가함에 따라, 신장 기능에 영향을 미치거나 신장에서 제대로 여과되지 않을 수 있는 특정 약물에 대한 용량 조절 또는 금기 사항에 대한 권고를 받는 사람이 더 많아질 수 있습니다.
코로나19 영향 분석
코로나19 팬데믹은 의료 시스템과 시장에 중간 정도의 영향을 미쳤습니다. 2020년 4월 medRXiv에 발표된 연구에 따르면, COVID-19로 인한 요실금은 다양한 감염성 질환을 앓고 있는 사람들에게서 흔히 관찰되었습니다. 경증 COVID-19에 감염된 0~12세 어린이에게서 요로 감염이 발견되었습니다.
COVID-19로 인한 요로 감염은 발병 후 1일에서 5일 사이에 확인되었습니다. 신장 기능 지표는 신장 기능이 얼마나 잘 작동하는지를 판단하는 데 사용됩니다. 일부 지표는 방사성 및 비방사성이며, 신장의 사구체 여과율과 농축 및 희석 능력(세뇨관 기능)을 보여줍니다. 많은 사람들이 온라인보다는 오프라인 매장에서 신장 기능 검사를 구매하는 것을 선호합니다.
러시아-우크라이나 전쟁 영향 분석
러시아-우크라이나 전쟁은 해당 지역의 낮은 발병률과 주요 시장 참여자의 부재로 인해 전 세계 신장 기능 검사 시장에 미미한 영향을 미칠 것으로 예상됩니다. 그러나 원자재, 검사 제품 및 장비의 수출입은 예측 기간 동안 전 세계 신장 기능 검사 시장에 큰 영향을 미치지 않을 것으로 예상됩니다.
인공지능 영향 분석
인공지능은 전 세계 신장 기능 검사 시장에 긍정적인 영향을 미칠 것으로 예상됩니다. 인공지능 기반 의사결정 지원 시스템은 의료진이 신장 진단 및 치료 옵션에 대해 정보에 입각한 판단을 내리는 데 도움을 줄 수 있습니다. 이러한 시스템은 환자 데이터를 분석하고 최신 의학 지식과 비교하여 근거 기반 지침에 따라 제안을 제시할 수 있습니다. 이는 의사가 특정 환자에게 가장 적합한 진단 검사, 약물 또는 조치를 선택하는 데 도움이 됩니다.
세분화 분석
전 세계 신장 기능 검사 시장은 제품 유형, 검사 유형, 최종 사용자 및 지역별로 세분화됩니다.
소변 검사지(Dipstick) 부문이 예측 기간 동안 신장 기능 검사 시장 점유율의 대부분을 차지할 것으로 예상됩니다.
소변 검사지(Dipstick) 제품 유형은 예측 기간 동안 전체 신장 기능 검사 시장의 약 47.3%를 차지할 것으로 예상됩니다. 소변 검사지는 일반적으로 몇 분 이내에 신속한 결과를 제공하여 신장 건강을 즉시 평가할 수 있도록 합니다. 사용하기 쉽고 광범위한 실험실 장비나 전문 교육이 필요하지 않아 병원, 응급실, 가정 등 다양한 의료 환경에서 활용 가능합니다.
이는 만성 신장 질환, 방광염, 신장 결석 등 다양한 신장 및 비뇨기 질환 진단에 도움이 됩니다. 또한 신장 기능 검사에 대한 수요 증가와 주요 기업들의 전략 추진이 시장 성장을 촉진하고 있습니다.
예를 들어, 스웨덴의 Elypta AB는 2020년 1월 소변 암 검진 검사 개발을 위해 700만 달러를 투자받았습니다. 환자의 소변에서 건강 상태에 대한 많은 정보를 얻을 수 있기 때문에 소변 검사 스틱의 사용이 증가하고 있습니다. 따라서 위의 내용을 종합해 볼 때, 이 시장 부문은 예측 기간 동안 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.
지역 분석
북미, 세계 신장 기능 검사 시장에서 주도적인 위치 차지
북미 지역은 예측 기간 동안 전 세계 신장 기능 검사 시장에서 약 39.4%의 점유율을 차지하며 두 번째로 큰 시장 점유율을 기록할 것으로 예상됩니다. 잘 구축된 의료 인프라, 만성 신장 질환(CKD)에 대한 광범위한 인식, 유리한 의료비 상환 정책 및 정부 지원 사업 덕분에 이 지역은 성장세를 보이고 있습니다. 또한, 주요 제조업체들은 혁신적인 제품 개발에 주력하고 있습니다.
예를 들어, Abbott HealthTab은 2021년 11월 Abbott와 휴대용 혈액화학 분석기인 i-STAT Alinity에 대한 양도 불가능한 시범 공급 유통 계약을 체결했습니다. 이 파트너십을 통해 HealthTab은 Abbott의 현장 진단용 i-STAT Alinity와 관련 크레아티닌 검사 키트를 캐나다 약국에서 판매하여 환자들에게 신장 기능에 대한 중요한 정보를 제공할 수 있게 되었습니다.
경쟁 환경
이 시장의 주요 글로벌 업체로는 F. Hoffmann-La Roche Ltd, Nova Biomedical, Quest Diagnostics, 77 Elektronika Kft, ACON Laboratories, Inc., Beckman Coulter, Abbott, bioMérieux SA, OPTI Medical, Siemens Healthineers 등이 있습니다.
보고서 구매 이유

• 제품 유형, 검사 유형, 최종 사용자 및 지역별 글로벌 신장 기능 검사 시장 세분화를 시각화하고 주요 상업 자산 및 주요 업체를 파악합니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 발굴합니다.

• 모든 세그먼트를 포함한 신장 기능 검사 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품을 모두 포함한 제품 맵핑 자료를 Excel 파일로 제공합니다.

글로벌 신장 기능 검사 시장 보고서는 약 53개의 표, 54개의 그림, 195페이지 분량입니다.
주요 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Market Overview
The Global Kidney Function Tests Market reached US$ 0.9 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 1.4 billion by 2030. The market is expected to exhibit a CAGR of 6.3% during the forecast period 2023-2030.
Kidney function tests identify kidney or renal function disorders and assist doctors in prescribing appropriate medicine. Dilution tests, clearance tests and other types of kidney function tests are available. Kidney diseases such as trouble urinating due to excess bodily fluids, edema in the hands or feet, and swollen face can be identified using a kidney function test.
The factors driving the growth of the market include FDA approvals and the launch of new products by the key players for kidney function tests. For instance, on July 12, 2022, Healthy.io, the global pioneer in integrating the smartphone camera into a medical device, announced that the Minuteful Kidney test has acquired 510(k) clearance from the US Food and Drug Administration (FDA) for home use.
Market Dynamics
Increasing the Prevalence of Kidney Diseases will Drive the Kidney Function Tests Market Growth
The global rise in the incidence and prevalence of chronic kidney disease is a major factor driving the growth of the global kidney function testing market. For instance, according to NIDDK 2021, Chronic kidney disease (CKD) affects more than one in every seven adults in the United States, totaling an estimated 37 million people.
The risk of CKD is even higher for Americans who have diabetes or high blood pressure, the two most frequent causes of kidney disease. Kidney disease affects nearly one-third of people with diabetes and one-fifth of people with high blood pressure.
Additionally, according to the Centers for Disease Control and Prevention’s (CDC) Chronic Kidney Disease in the United States, 2021, CKD is slightly more prevalent in women (14%) than in men (12%), and it is more common in non-Hispanic Black adults (16%) than in non-Hispanic white adults (13%) or non-Hispanic Asian people (13%). Thus, the frequency of CKD will fuel market expansion.
High Diagnostic Process Costs are Expected to Hamper the Market Growth
The high cost of kidney function tests, as well as the low acceptance rate in emerging and developing nations, will stifle market expansion. The increased number of people with a clinical diagnosis of kidney disease as a result of the modified formula means that more people may receive recommendations for dose adjustments or contraindications for certain drugs that may interfere with kidney function or be poorly filtered by the kidneys.
COVID-19 Impact Analysis
The pandemic of COVID-19 has had a moderate impact on healthcare systems and the market. According to a study published in medRXiv in April 2020, COVID-19 urine incontinence was often observed in persons with a variety of infectious and harmful illnesses. Children aged 0 to 12 who have a little light type of COVID-19 have been found to have urinary tract COVID-19 exposure.
COVID-19 urinary tract infections were identified between the first and fifth days after the disease's onset. Kidney function markers are used to determine how well the kidneys function. Some signals are radioactive as well as non-radioactive. They demonstrate the kidneys' glomerular filtration rate as well as their concentrating and diluting capacities (tubular function). Many people would rather buy a kidney function test at a store than online.
Russia-Ukraine War Impact Analysis
The Russia-Ukraine is estimated to have a minimal impact on the global kidney function tests market owing to the low prevalence and absence of key market players in this region. However, the impact of the import and export of raw materials, test products and devices is anticipated to have little influence over the global kidney function tests market in the forecast period.
Artificial Intelligence Impact Analysis
Artificial intelligence is anticipated to impact the global preeclampsia market positively. Artificial intelligence-powered decision support systems can help healthcare personnel make well-informed judgements about renal diagnosis and treatment options. These systems are capable of analyzing patient data, comparing it to current medical knowledge and making suggestions based on evidence-based guidelines. This assists doctors in selecting the best diagnostic tests, drugs or actions for particular patients.
Segment Analysis
The global kidney function tests market is segmented based on product type, test type end user and region.
The Dipstick Segment is Estimated to Hold the Majority of the Kidney Function Tests Market Share During the Forecast Period
The Dipstick product type holds about 47.3% of the total kidney function tests market in the forecast period. Dipstick tests provide rapid results, usually within a few minutes, allowing for immediate assessment of kidney health. They are easy to use and do not require extensive laboratory equipment or specialized training, making them accessible in various healthcare settings, including clinics, emergency rooms and home.
This aids in the diagnosis of a variety of renal and urinary issues, including chronic kidney disease, bladder infections and kidney stones. Furthermore, the increasing number of people and important companies' strategies in renal function testing promote some growth.
For instance, Sweden's Elypta AB raised USD 7.0 million in January 2020 for a urine cancer screening test. Therefore, a patient's urine can reveal a lot of information about their health, increasing the use of dipsticks. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.
Geographical Analysis
North America Holds a Dominant Position in the Global Kidney Function Tests Market
The North American region holds the second-largest share of the global kidney function tests market accounting for approximately 39.4% in the forecast period. Due to well-established healthcare infrastructure, widespread awareness of CKD and favorable reimbursement policies and government initiatives. Furthermore, the region's main manufacturers are focused on inventing innovative products.
For instance, Abbott HealthTab signed a non-assignable, pilot supplier distribution agreement with Abbott in November 2021 for i-STAT Alinity, a handheld blood chemistry analyzer. The partnership allows HealthTab to sell Abbott's POC i-STAT Alinity and associated creatinine tests in Canadian pharmacies, providing patients with important information regarding their kidney functioning.
Competitive Landscape
The major global players in the market include F. Hoffmann-La Roche Ltd, Nova Biomedical, Quest Diagnostics, 77 Elektronika Kft, ACON Laboratories, Inc., Beckman Coulter, Abbott, bioMérieux SA, OPTI Medical, Siemens Healthineers. among others.
Why Purchase the Report?
• To visualize the global kidney function tests market segmentation based on product type, test type, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of kidney function tests market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available in Excel consisting of key products of all the major players.
The Global Kidney Function Tests Market Report Would Provide Approximately 53 Tables, 54 Figures and 195 Pages.
Target Audience 2023
• Manufacturers / Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Test Type
3.3. Snippet by End User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing product launches for kidney function tests
4.1.1.2. Increasing the prevalence of kidney diseases
4.1.2. Restraints
4.1.2.1. High diagnostic process costs growth
4.1.3. Opportunity
4.1.3.1. Kidney function tests help healthcare providers develop individualized treatment plans for patients
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's 5 Force Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion
7. Russia-Ukraine War Analysis
8. Artificial Intelligence Impact Analysis
9. By Product Type
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.1.2. Market Attractiveness Index, By Product Type
9.2. Dipsticks
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Reagents
9.4. Disposables
9.5. Others
10. By Test Type
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
10.1.2. Market Attractiveness Index, By Test Type
10.2. Urine test
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Blood test
10.4. Others
11. By End User
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.1.2. Market Attractiveness Index, By End User
11.2. Hospitals
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Diagnostic Centers
11.4. Research laboratories and institutes
11.5. Others
12. By Region
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.2.6.1. The U.S.
12.2.6.2. Canada
12.2.6.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.3.6.1. Germany
12.3.6.2. The U.K.
12.3.6.3. France
12.3.6.4. Italy
12.3.6.5. Spain
12.3.6.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.6.1. Brazil
12.4.6.2. Argentina
12.4.6.3. Rest of South America
12.5. Asia-Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.5.6.1. China
12.5.6.2. India
12.5.6.3. Japan
12.5.6.4. Australia
12.5.6.5. Rest of Asia-Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13. Competitive Landscape
13.1. Competitive Scenario
13.2. Market Share Analysis
13.3. Mergers and Acquisitions Analysis
14. Company Profiles
14.1. F. Hoffmann-La Roche Ltd
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Financial Overview
14.1.4. Key Developments
14.2. Nova Biomedical
14.3. Quest Diagnostics
14.4. 77 Elektronika Kft
14.5. ACON Laboratories, Inc.
14.6. Beckman Coulter
14.7. Abbott
14.8. bioMérieux SA
14.9. OPTI Medical
14.10. Siemens Healthineers.
LIST NOT EXHAUSTIVE
15. Appendix
15.1. About Us and Services
15.2. Contact Us

언급된 주요 기업들

F. Hoffmann-La Roche Ltd, 4.	Key Developments, Nova Biomedical, Quest Diagnostics, 77 Elektronika Kft, ACON Laboratories, Inc., Beckman Coulter, Abbott, bioMérieux SA, OPTI Medical, Siemens Healthineers.

표 목록 (Tables)

List of Tables

Table1 Global Kidney Function Tests Market Value, By Product Type, 2021, 2025 & 2029 ($ Million)

Table2 Global Kidney Function Tests Market Value, By Test type, 2021, 2025 & 2029 ($ Million)

Table3 Global Kidney Function Tests Market Value, By End user, 2021, 2025 & 2029 ($ Million)

Table4 Global Kidney Function Tests Market Value, By Region, 2021, 2025 & 2029 ($ Million)

Table5 Global Kidney Function Tests Market Value, By Product Type, 2021, 2025 & 2029 ($ Million)

Table6 Global Kidney Function Tests Market Value, By Product Type, 2020-2029 ($ Million)

Table7 Global Kidney Function Tests Market Value, By Test type, 2021, 2025 & 2029 ($ Million)

Table8 Global Kidney Function Tests Market Value, By Test type, 2020-2029 ($ Million)

Table9 Global Kidney Function Tests Market Value, By End user, 2021, 2025 & 2029 ($ Million)

Table10 Global Kidney Function Tests Market Value, By End user, 2020-2029 ($ Million)

Table11 Global Kidney Function Tests Market Value, By Region, 2021, 2025 & 2029 ($ Million)

Table12 Global Kidney Function Tests Market Value, By Region, 2020-2029 ($ Million)

Table13 North America Kidney Function Tests Market Value, By Product Type, 2020-2029 ($ Million)

Table14 North America Kidney Function Tests Market Value, By Test type, 2020-2029 ($ Million)

Table15 North America Kidney Function Tests Market Value, By End user, 2020-2029 ($ Million)

Table16 North America Kidney Function Tests Market Value, By Country, 2020-2029 ($ Million)

Table17 South America Kidney Function Tests Market Value, By Product Type, 2020-2029 ($ Million)

Table18 South America Kidney Function Tests Market Value, By Test type, 2020-2029 ($ Million)

Table19 South America Kidney Function Tests Market Value, By End user, 2020-2029 ($ Million)

Table20 South America Kidney Function Tests Market Value, By Country, 2020-2029 ($ Million)

Table21 Europe Kidney Function Tests Market Value, By Product Type, 2020-2029 ($ Million)

Table22 Europe Kidney Function Tests Market Value, By Test type, 2020-2029 ($ Million)

Table23 Europe Kidney Function Tests Market Value, By End user, 2020-2029 ($ Million)

Table24 Europe Kidney Function Tests Market Value, By Country, 2020-2029 ($ Million)

Table25 Asia-Pacific Kidney Function Tests Market Value, By Product Type, 2020-2029 ($ Million)

Table26 Asia-Pacific Kidney Function Tests Market Value, By Test type, 2020-2029 ($ Million)

Table27 Asia-Pacific Kidney Function Tests Market Value, By End user, 2020-2029 ($ Million)

Table28 Asia-Pacific Kidney Function Tests Market Value, By Country, 2020-2029 ($ Million)

Table29 Middle East & Africa Kidney Function Tests Market Value, By Product Type, 2020-2029 ($ Million)

Table30 Middle East & Africa Kidney Function Tests Market Value, By Test type, 2020-2029 ($ Million)

Table31 Middle East & Africa Kidney Function Tests Market Value, By End user, 2020-2029 ($ Million)

Table32 F. Hoffmann-La Roche Ltd: Overview

Table33 F. Hoffmann-La Roche Ltd: Product Portfolio

Table34 F. Hoffmann-La Roche Ltd: Key Developments

Table35 Nova Biomedical: Overview

Table36 Nova Biomedical: Product Portfolio

Table37 Nova Biomedical: Key Developments

Table38 Quest Diagnostics: Overview

Table39 Quest Diagnostics: Product Portfolio

Table40 Quest Diagnostics: Key Developments

Table41 77 Elektronika Kft: Overview

Table42 77 Elektronika Kft: Product Portfolio

Table43 77 Elektronika Kft: Key Developments

Table44 ACON Laboratories, Inc.: Overview

Table45 ACON Laboratories, Inc.: Product Portfolio

Table46 ACON Laboratories, Inc.: Key Developments

Table47 Beckman Coulter: Overview

Table48 Beckman Coulter: Product Portfolio

Table49 Beckman Coulter: Key Developments

Table50 Abbott: Overview

Table51 Abbott: Product Portfolio

Table52 Abbott: Key Developments

Table53 bioMérieux SA: Overview

Table54 bioMérieux SA: Product Portfolio

Table55 bioMérieux SA: Key Developments

Table56 OPTI Medical: Overview

Table57 OPTI Medical: Product Portfolio

Table58 OPTI Medical: Key Developments

Table59 Siemens Healthineers: Overview

Table60 Siemens Healthineers: Product Portfolio

Table61 Siemens Healthineers: Key Developments

그림 목록 (Figures)

List of Figures

Figure1 Global Kidney Function Tests Market Share, By Product Type, 2020 & 2029 (%)

Figure2 Global Kidney Function Tests Market Share, By Test type, 2020 & 2029 (%)

Figure3 Global Kidney Function Tests Market Share, By End user, 2020 & 2029 (%)

Figure4 Global Kidney Function Tests Market Share, By Region, 2020 & 2029 (%)

Figure5 Global Kidney Function Tests Market Value, 2020-2029 ($ Million)

Figure6 Global Kidney Function Tests Market Y-o-Y Growth, By Product Type, 2020-2028 (%)

Figure7 Dipsticks: Global Kidney Function Tests Market Value, 2020-2029 ($ Million)

Figure8 Reagents: Global Kidney Function Tests Market Value, 2020-2029 ($ Million)

Figure9 Disposables: Global Kidney Function Tests Market Value, 2020-2029 ($ Million)

Figure10 Others: Global Kidney Function Tests Market Value, 2020-2029 ($ Million)

Figure11 Global Kidney Function Tests Market Y-o-Y Growth, By Test type, 2020-2028 (%)

Figure12 Urine test: Global Kidney Function Tests Market Value, 2020-2029 ($ Million)

Figure13 Blood test: Global Kidney Function Tests Market Value, 2020-2029 ($ Million)

Figure14 Others: Global Kidney Function Tests Market Value, 2020-2029 ($ Million)

Figure15 Global Kidney Function Tests Market Y-o-Y Growth, By End user, 2020-2028 (%)

Figure16 Hospitals: Global Kidney Function Tests Market Value, 2020-2029 ($ Million)

Figure17 Diagnostic Centers: Global Kidney Function Tests Market Value, 2020-2029 ($ Million)

Figure18 Research laboratories and institutes: Global Kidney Function Tests Market Value, 2020-2029 ($ Million)

Figure19 Others: Global Kidney Function Tests Market Value, 2020-2029 ($ Million)

Figure20 Global Kidney Function Tests Market Y-o-Y Growth, By Region, 2020-2028 (%)

Figure21 North America Kidney Function Tests Market Value, 2020-2029 ($ Million)

Figure22 North America Kidney Function Tests Market Share, By Product Type, 2020 & 2029 (%)

Figure23 North America Kidney Function Tests Market Share, By Test type, 2020 & 2029 (%)

Figure24 North America Kidney Function Tests Market Share, By End user, 2020 & 2029 (%)

Figure25 North America Kidney Function Tests Market Share, By Country, 2020 & 2029 (%)

Figure26 South America Kidney Function Tests Market Value, 2020-2029 ($ Million)

Figure27 South America Kidney Function Tests Market Share, By Product Type, 2020 & 2029 (%)

Figure28 South America Kidney Function Tests Market Share, By Test type, 2020 & 2029 (%)

Figure29 South America Kidney Function Tests Market Share, By End user, 2020 & 2029 (%)

Figure30 South America Kidney Function Tests Market Share, By Country, 2020 & 2029 (%)

Figure31 Europe Kidney Function Tests Market Value, 2020-2029 ($ Million)

Figure32 Europe Kidney Function Tests Market Share, By Product Type, 2020 & 2029 (%)

Figure33 Europe Kidney Function Tests Market Share, By Test type, 2020 & 2029 (%)

Figure34 Europe Kidney Function Tests Market Share, By End user, 2020 & 2029 (%)

Figure35 Europe Kidney Function Tests Market Share, By Country, 2020 & 2029 (%)

Figure36 Asia-Pacific Kidney Function Tests Market Value, 2020-2029 ($ Million)

Figure37 Asia-Pacific Kidney Function Tests Market Share, By Product Type, 2020 & 2029 (%)

Figure38 Asia-Pacific Kidney Function Tests Market Share, By Test type, 2020 & 2029 (%)

Figure39 Asia-Pacific Kidney Function Tests Market Share, By End user, 2020 & 2029 (%)

Figure40 Asia-Pacific Kidney Function Tests Market Share, By Country, 2020 & 2029 (%)

Figure41 Middle East & Africa Kidney Function Tests Market Value, 2020-2029 ($ Million)

Figure42 Middle East & Africa Kidney Function Tests Market Share, By Product Type, 2020 & 2029 (%)

Figure43 Middle East & Africa Kidney Function Tests Market Share, By Test type, 2020 & 2029 (%)

Figure44 Middle East & Africa Kidney Function Tests Market Share, By End user, 2020 & 2029 (%)

Figure45 F. Hoffmann-La Roche Ltd: Financials

Figure46 Nova Biomedical: Financials

Figure47 Quest Diagnostics: Financials

Figure48 77 Elektronika Kft: Financials

Figure49 ACON Laboratories, Inc.: Financials

Figure50 Beckman Coulter: Financials

Figure51 Abbott: Financials

Figure52 bioMérieux SA: Financials

Figure53 OPTI Medical: Financials

Figure54Siemens Healthineers: Financials

글로벌 신장 기능 검사 시장 – 2023-2030

Global Kidney Function Tests Market - 2023-2030